U.S. Enzymes Market Size & Outlook, 2021-2030
U.S. enzymes market, 2018-2030 (US$M)
Related Markets
U.S. enzymes market highlights
- The U.S. enzymes market generated a revenue of USD 3,158.7 million in 2021 and is expected to reach USD 5,693.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.8% from 2022 to 2030.
- In terms of segment, industrial enzymes was the largest revenue generating type in 2021.
- Specialty Enzymes is the most lucrative type segment registering the fastest growth during the forecast period.
Enzymes market data book summary
| Market revenue in 2021 | USD 3,158.7 million |
| Market revenue in 2030 | USD 5,693.9 million |
| Growth rate | 6.8% (CAGR from 2021 to 2030) |
| Largest segment | Industrial enzymes |
| Fastest growing segment | Specialty Enzymes |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Industrial Enzymes, Specialty Enzymes |
| Key market players worldwide | BASF, Novonesis AS ADR, DuPont de Nemours Inc, DSM, Novus Holdings Ltd, Associated British Foods PLC, Advanced Enzymes, Bluestar Adisseo Co., Chr. Hansen, Lesaffre |
Other key industry trends
- In terms of revenue, U.S. accounted for 27.5% of the global enzymes market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. enzymes market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 5,693.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Enzymes Market Scope
Enzymes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. enzymes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to enzymes market will help companies and investors design strategic landscapes.
Industrial enzymes was the largest segment with a revenue share of 55.76% in 2021. Horizon Databook has segmented the U.S. enzymes market based on industrial enzymes, specialty enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is a prominent country in the region on the account of the presence of various end-use industries in the country, thus resulting in increased product consumption. Carbohydrate is widely used as digestive enzyme in a wide array of industrial sectors including food & beverage and pharmaceutical.
Moreover, rising demand for functional foods and dietary fibers is driving the market demand for carbohydrase in the country. The demand for specialty enzymes is anticipated to rise significantly due to the stable growth of their key application segments including pharmaceutical and research & biotechnology in the country.
Alpha-amylase, glucoamylase, and beta-glucanase are some of the major enzymes used in food processing applications. In the US, enzymes are widely used in the pharmaceutical sector due to the presence of prominent pharmaceutical market players such as Pfizer Inc., Amgen Inc., and Merck & Co., Inc.
Reasons to subscribe to U.S. enzymes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. enzymes market databook
-
Our clientele includes a mix of enzymes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. enzymes market , including forecasts for subscribers. This country databook contains high-level insights into U.S. enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. enzymes market size, by type, 2018-2030 (US$M)
U.S. Enzymes Market Outlook Share, 2021 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
